Carey Macrury

Stock Analyst at Canaccord Genuity

(1.26)
# 1799
Out of 5,218 analysts
15
Total ratings
50.00%
Success rate
22.16%
Average return
7 Stocks
Name Action Price Target Current % Upside Ratings Updated
Iamgold
Upgrades: Buy
8 11
5.34 96.63% 2 Oct 22, 2024
Gatos Silver
Downgrades: Hold
n/a
n/a n/a 2 Oct 22, 2024
Aptose Biosciences
Maintains: Buy
195 120
0.19 63057.89% 1 Mar 27, 2023
Newmont
Upgrades: Buy
53 55
40.27 36.58% 6 Mar 14, 2023
Royal Gold
Upgrades: Buy
151 140
146.99 -4.76% 2 Jun 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Speculative Buy
18 15
5.83 148.71% 1 Apr 21, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
115 110
83.89 31.12% 1 Feb 23, 2021